Article
The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
Clinical immunology (Orlando, Fla.) - 1 Dec 2006
Olesen H V, Jensenius J C, Steffensen R, Thiel S, Schiøtz P O
Abstract excerpt
The lectin pathway of complement activation is initiated by mannan-binding lectin (MBL) or the ficolins through the common MBL-associated serine protease-2 (MASP-2). Deficiency of MBL has been associated with poorer outcome in cystic fibrosis (CF). We investigated the MBL pathway further by analysis of the MASP-2 deficiency mutation (D105G) as well as MBL-2 genotypes. Concentrations and genotypes of MASP-2 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.